• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Lux Capital

edit

Lux Capital Management is a research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth sectors. Our investment team has built over 20 companies from scratch. Lux’s investment strategy ensures our portfolio companies are better connected, have deeper insight, and command industry leadership faster than their competitors.

Recent Milestones

edit

• 
  Lux Capital invested in Shapeways. (4/23/13)
  Posted 4/24/13 at 6:09pm via techcrunch.com
• 
  Lux Capital invested in Matterport. (3/7/13)
  Posted 3/7/13 at 6:48pm via finsmes.com
• 
  Lux Capital invested in Kala Pharmaceuticals. (2/28/13)
  Posted 2/28/13 at 6:27pm via finsmes.com
• 
  Lux Capital invested in Kyruus. (1/2/13)
  Posted 1/2/13 at 6:52pm via kyruus.com
• 
  Lux Capital invested in Visterra. (11/9/12)
  Posted 11/10/12 at 2:07am via pehub.com
• 
  Lux Capital invested in Genocea Biosciences. (10/10/12)
  Posted 10/10/12 at 7:37pm via masshightech.com
• 
  Lux Capital invested in Kymeta. (8/21/12)
  Posted 8/21/12 at 6:21pm via finsmes.com
• 
  Lux Capital invested in Siluria Technologies. (7/26/12)
  Posted 7/26/12 at 4:20am via marketwire.com
• 
  Lux Capital invested in Shapeways. (6/19/12)
  Posted 6/19/12 at 6:10pm via techcrunch.com
• 
  Lux Capital invested in Kala Pharmaceuticals. (3/14/12)
  Posted 3/14/12 at 5:48am via finsmes.com
• 
  Lux Capital invested in Luxtera. (2/27/12)
  Posted 2/27/12 at 7:32pm via luxtera.com
• 
  Lux Capital invested in Cerulean Pharma. (12/15/11)
  Posted 12/15/11 at 6:42pm via finsmes.com
• 
  Lux Capital invested in Siluria Technologies. (9/27/11)
  Posted 9/27/11 at 6:31pm via finsmes.com
• 
  Lux Capital invested in Transphorm. (6/23/11)
  Posted 6/23/11 at 8:13pm via finsmes.com
• 
  Lux Capital invested in Transphorm. (2/23/11)
  Posted 2/23/11 at 6:50pm via techcrunch.com
• 
  Lux Capital invested in Genocea Biosciences. (1/3/11)
  Posted 1/3/11 at 6:08pm via finsmes.com

Investments

Videos

Sources

1. Lux Capital Closes Third Fund at $245M (finsmes.com) [edit]
2. 3D Printing Company Shapeways Raises $30 Million C Round Led By Andreessen Horowitz (techcrunch.com) [edit]
3. Matterport Raises $5.6M Series A Financing (finsmes.com) [edit]
4. Kala Pharmaceuticals Raises $11.5M in Series A Equity Financing (finsmes.com) [edit]
5. Kyruus Raises $11M Series B to Accelerate the Rapid Growth of its Physician Network Management Solutions (kyruus.com) [edit]
6. Visterra Adds $13M to Wrap Up Series A (pehub.com) [edit]
7. Genocea raises $30M to advance herpes vaccine (masshightech.com) [edit]
8. Kymeta Closes $12M Funding (finsmes.com) [edit]
9. Siluria Technologies Raises $30 Million in Series C Funding to Commercialize Its Process Technology for Converting Natural Gas Into Commodity Chemicals and Transportation Fuels (marketwire.com) [edit]
10. After Printing Over 1M 3D Objects, Shapeways Raises $6.2M Round Led By Lux Capital (techcrunch.com) [edit]
11. Kala Pharmaceuticals Raises $6.2M in Equity Financing (finsmes.com) [edit]
12. Luxtera Closes $21.7 Million of Financing and Adds Former Broadcom Executive Martin Colombatto to Board of Directors (luxtera.com) [edit]
13. Cerulean Pharma Closes $15m Series D Financing (finsmes.com) [edit]
14. Siluria Technologies Raises $20M in Series B Financing (finsmes.com) [edit]
15. Transphorm Completes $25M Series D Financing (finsmes.com) [edit]
16. Energy Efficiency Startup Transphorm Emerges From Stealth, Raises $20 Million From Google Ventures (techcrunch.com) [edit]
17. Genocea Biosciences Closes $35M Series B Financing Round (finsmes.com) [edit]
18. Cerulean Pharma Closes $24M Series C Financing (finsmes.com) [edit]
19. Kleiner-Backed Siluria Raises Funds for Greener Building Blocks (gigaom.com) [edit]
20. Crystal IS Taps Investors For $4M To Market Water-Purification LEDs (fis.dowjones.com) [edit]
21. Visterra, Inc.: Series A $6M (onbiovc.com) [edit]
22. Cambrios lands $14.5M for electronic display components (deals.venturebeat.com) [edit]
23. Cerulean pockets $10M as it catapults into the clinic (fiercebiotech.com) [edit]
24. Parasol Therapeutics, Inc.: Series A $3.25M (onbiovc.com) [edit]
25. EDGAR [edit]
26. Tempo Pharmaceuticals Closes $8 Million in Series B Funding (ceruleanrx.com) [edit]
27. Silicon Clocks raises $8M more for chip timing. (venturebeat.com) [edit]
28. Tempo Pharmaceuticals Closes $12.1 Million in Series A Funding (ceruleanrx.com) [edit]
29. Crystal IS, Inc. Raises $10.6 Million in Second Round Financing. (highbeam.com) [edit]
30. EDGAR [edit]
31. Cambrios Technology Announces $12 Million Series B Round (cambrios.com) [edit]